Nanoscope Therapeutics Publishes New Study Advancing Functional Vision Assessment in Retinal Disease
Nanoscope Therapeutics announced the publication of a new peer-reviewed study highlighting improved methods for assessing functional vision in patients with severe retinal diseases. The study evaluated real-world visual performance in patients with significant vision loss, helping demonstrate meaningful functional improvements beyond traditional eye chart measurements. These findings support the development of more practical clinical endpoints and reinforce Nanoscope’s efforts to advance innovative vision-restoring therapies. 
Nanoscope Therapeutics Publishes New Study Advancing Functional Vision Assessment in Retinal Disease